Victoria Vu

Gates (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index689citations30works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(7), Ubiquitin and proteasome pathways(6), Protein Degradation and Inhibitors(6), Cancer-related gene regulation(4), Hippo pathway signaling and YAP/TAZ(3)

Publications30 total

Advancing the science of recruitment for Alzheimer’s clinical trials: Challenges and opportunities
The Journal of Prevention of Alzheimer s Disease·2025· 1 citedOpen Access
Abstract 6978: Discovery and characterization of BAY-805, a potent and selective DUB inhibitor of ubiquitin specific peptidase USP21
Cancer Research·2025
Probing the CRL4DCAF12 interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons
PNAS Nexus·2024· 4 citedOpen Access
Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations
Experimental Hematology·2023· 5 citedOpen Access
Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration
ACS Medicinal Chemistry Letters·2023· 13 citedOpen Access
Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations
2023Open Access
Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings
Bioorganic & Medicinal Chemistry Letters·2023· 10 cited
Probing the DCAF12 interactions with MAGEA3 and CCT5 C-terminal degrons
2023Open Access
Minimal Risk Manoeuvre Strategies for Cooperative and Collaborative Automated Vehicles
2023· 3 citedOpen Access
A Unified Taxonomy for Automated Vehicles: Individual, Cooperative, Collaborative, On-Road, and Off-Road
arXiv (Cornell University)·2023· 3 citedOpen Access
Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21
Journal of Medicinal Chemistry·2023· 24 citedOpen Access
HiBiT Cellular Thermal Shift Assay (HiBiT CETSA)
Methods in molecular biology·2023· 12 citedOpen Access
Development of Lm-41 and Af-2112, Two Flufenamic Acid-Derived Tead Inhibitors Obtained Through the Replacement of the Trifluoromethyl Group by Aryl Rings
SSRN Electronic Journal·2023· 1 citedOpen Access
Validating Small Molecule Chemical Probes for Biological Discovery
Annual Review of Biochemistry·2022· 25 cited
PRMT5 regulates ATF4 transcript splicing and oxidative stress response
Redox Biology·2022· 32 citedOpen Access
PRMT5 regulates ATF4 transcript splicing and oxidative stress response
2022· 1 citedOpen Access
A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization
Nature Chemical Biology·2021· 102 citedOpen Access
Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
Journal of Visualized Experiments·2021· 1 cited
Development of LM98, a Small‐Molecule TEAD Inhibitor Derived from Flufenamic Acid
ChemMedChem·2021· 32 cited
PRMT5 inhibition disrupts splicing and stemness in glioblastoma
Nature Communications·2021· 206 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Dalia Baršytė-Lovejoy(20), Magdalena M. Szewczyk(12), C.H. Arrowsmith(8), Vijayaratnam Santhakumar(8), Masoud Vedadi(7), Fengling Li(6), Abdellah Allali‐Hassani(5), Albina Bolotokova(4), Ahmed Fnaiche(4), Narjara González Suárez(4), Borhane Annabi(4), Alexandre Gagnon(4), Genna M. Luciani(4), Mark D. Minden(4), Mathieu Lupien(3), David Dilworth(3), Mona Alqazzaz(3), Peter J. Brown(3), Léa Mélin(3), Hong Zeng(3)